Using apoferritin as suitable nanocarrier for siRNA to achieve active targeting to cancer cells

European & Global Summit for Clinical Nanomedicine and Targeted Medicine

CHAROUSOVÁ, M.; DOSTÁLOVÁ, S.; HEGER, Z.; ADAM, V., 2018: Using apoferritin as suitable nanocarrier for siRNA to achieve active targeting to cancer cells. EUROPEAN & GLOBAL SUMMIT FOR CLINICAL NANOMEDICINE AND TARGETED MEDICINE , p. 173 - 2; FULL TEXT

Research Groups:

CEITEC authors: